Opaleye Management Inc. - Sep 10, 2024 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
ETON
Transactions as of
Sep 10, 2024
Transactions value $
$504,875
Form type
4
Date filed
9/12/2024, 07:31 PM
Previous filing
Sep 12, 2024
Next filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Purchase $233K +50K +1.92% $4.65 2.66M Sep 10, 2024 By Opaleye, L.P. F1, F3
transaction ETON Common Stock, par value $0.001 per share Purchase $34.9K +7.5K +12% $4.65 70K Sep 10, 2024 By Managed account F2, F3
transaction ETON Common Stock, par value $0.001 per share Purchase $214K +45K +1.69% $4.75 2.71M Sep 11, 2024 By Opaleye, L.P. F1, F3
transaction ETON Common Stock, par value $0.001 per share Purchase $23.8K +5K +7.14% $4.75 75K Sep 11, 2024 By Managed account F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F3 Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.